Literature DB >> 28705316

Cell-Specific Pathways Supporting Persistent Fibrosis in Heart Failure.

Stephen D Farris1, Creighton Don1, Deri Helterline1, Christopher Costa1, Tabitha Plummer1, Susanne Steffes2, Claudius Mahr1, Nahush A Mokadam3, April Stempien-Otero4.   

Abstract

BACKGROUND: Only limited data exist describing the histologic and noncardiomyocyte function of human myocardium in end-stage heart failure (HF).
OBJECTIVES: The authors sought to determine changes in noncardiomyocyte cellular activity in patients with end-stage HF after left ventricular assist device (LVAD)-induced remodeling to identify mechanisms impeding recovery.
METHODS: Myocardium was obtained from subjects undergoing LVAD placement and/or heart transplantation. Detailed histological analyses were performed, and, when feasible, mononuclear cells were isolated from fresh, dissociated myocardium for quantitative reverse transcription polymerase chain reaction studies. Echocardiographic and catheterization data were obtained during routine care.
RESULTS: Sixty-six subjects were enrolled; 54 underwent 8.0 ± 1.2 months of LVAD unloading. Despite effective hemodynamic unloading and remodeling, there were no differences after LVAD use in capillary density (0.78 ± 0.1% vs. 0.9 ± 0.1% capillary area; n = 42 and 28, respectively; p = 0.40), cardiac fibrosis (25.7 ± 2.4% vs. 27.9 ± 2.4% fibrosis area; n = 44 and 31, respectively; p = 0.50), or macrophage density (80.7 ± 10.4 macrophages/mm2 vs. 108.6 ± 15 macrophages/mm2; n = 33 and 28, respectively; p = 0.1). Despite no change in fibrosis or myofibroblast density (p = 0.40), there was a 16.7-fold decrease (p < 0.01) in fibroblast-specific collagen expression. Furthermore, there was a shift away from pro-fibrotic/alternative pro-fibrotic macrophage signaling after LVAD use.
CONCLUSIONS: Despite robust cardiac unloading, capillary density and fibrosis are unchanged compared with loaded hearts. Fibroblast-specific collagen expression was decreased and might be due to decreased stretch and/or altered macrophage polarization. Dysfunctional myocardium may persist, in part, from ongoing inflammation and poor extracellular matrix remodeling. Understanding these changes could lead to improved therapies for HF.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  collagen; left ventricular assist device; myocardial biology; remodeling; translational studies

Mesh:

Substances:

Year:  2017        PMID: 28705316     DOI: 10.1016/j.jacc.2017.05.040

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  16 in total

Review 1.  The Effect of Left Ventricular Assist Device Therapy on Cardiac Biomarkers: Implications for the Identification of Myocardial Recovery.

Authors:  Luise Holzhauser; Gene Kim; Gabriel Sayer; Nir Uriel
Journal:  Curr Heart Fail Rep       Date:  2018-08

Review 2.  The Diabetic Cardiorenal Nexus.

Authors:  John A D'Elia; George P Bayliss; Larry A Weinrauch
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

3.  MBNL1 drives dynamic transitions between fibroblasts and myofibroblasts in cardiac wound healing.

Authors:  Darrian Bugg; Logan R J Bailey; Ross C Bretherton; Kylie E Beach; Isabella M Reichardt; Kalen Z Robeson; Anna C Reese; Jagadambika Gunaje; Galina Flint; Cole A DeForest; April Stempien-Otero; Jennifer Davis
Journal:  Cell Stem Cell       Date:  2022-02-16       Impact factor: 25.269

4.  Steroidogenic acute regulatory protein/aldosterone synthase mediates angiotensin II-induced cardiac fibrosis and hypertrophy.

Authors:  Wei-Wei Zhang; Rong-Hua Zheng; Feng Bai; Katelyn Sturdivant; Ning-Ping Wang; Erskine A James; Himangshu S Bose; Zhi-Qing Zhao
Journal:  Mol Biol Rep       Date:  2019-12-09       Impact factor: 2.316

5.  Framework to Classify Reverse Cardiac Remodeling With Mechanical Circulatory Support: The Utah-Inova Stages.

Authors:  Palak Shah; Mitchell Psotka; Iosif Taleb; Rami Alharethi; Mortada A Shams; Omar Wever-Pinzon; Michael Yin; Federica Latta; Josef Stehlik; James C Fang; Guoqing Diao; Ramesh Singh; Naila Ijaz; Christos P Kyriakopoulos; Wei Zhu; Christopher W May; Lauren B Cooper; Shashank S Desai; Craig H Selzman; Abdallah G Kfoury; Stavros G Drakos
Journal:  Circ Heart Fail       Date:  2021-05-05       Impact factor: 8.790

Review 6.  Cardiac fibrosis.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2021-05-25       Impact factor: 10.787

7.  CircUbe3a from M2 macrophage-derived small extracellular vesicles mediates myocardial fibrosis after acute myocardial infarction.

Authors:  Yan Wang; Chaofu Li; Ranzun Zhao; Zhimei Qiu; Changyin Shen; Zhenglong Wang; Weiwei Liu; Wei Zhang; Junbo Ge; Bei Shi
Journal:  Theranostics       Date:  2021-04-15       Impact factor: 11.556

Review 8.  Reverse Remodeling With Left Ventricular Assist Devices.

Authors:  Daniel Burkhoff; Veli K Topkara; Gabriel Sayer; Nir Uriel
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 23.213

9.  The Role of miRNA-132 against Apoptosis and Oxidative Stress in Heart Failure.

Authors:  Xuelei Liu; Zhou Tong; Keyan Chen; Xiaofang Hu; Hongxu Jin; Mingxiao Hou
Journal:  Biomed Res Int       Date:  2018-02-25       Impact factor: 3.411

Review 10.  Pyroptosis: A New Regulating Mechanism in Cardiovascular Disease.

Authors:  Nan Ji; Zhongwen Qi; Yueyao Wang; Xiaoya Yang; Zhipeng Yan; Meng Li; Qihui Ge; Junping Zhang
Journal:  J Inflamm Res       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.